Rheumatoid arthritis and aromatase inhibitors

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

Medicine, Oncology, Breast Oncology +6

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Pharmacy, Endocrinology, Oncology +13

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

N. Lynn Henry, Jon T. Giles, Dennis C. Ang et al. · Breast Cancer Research and Treatment · 2007 · 237 citations · Full text

Medicine, Oncology, Breast Oncology +13

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome

Leilani Morales, Steven Pans, Kilian Verschueren et al. · Journal of Clinical Oncology · 2008 · 149 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren's syndrome

Gil-Jin Shim, Margaret Warner, Hyun‐Jin Kim et al. · Proceedings of the National Academy of Sciences · 2004 · 138 citations · Full text

Medicine, Endocrinology, Immunology +17